Flagship Pioneering Fund Vi General Partner Llc - Net Worth and Insider Trading
Flagship Pioneering Fund Vi General Partner Llc Net Worth
The estimated net worth of Flagship Pioneering Fund Vi General Partner Llc is at least $2 Million dollars as of 2024-11-13. Flagship Pioneering Fund Vi General Partner Llc is the 10% Owner of Omega Therapeutics Inc and owns about 2,197,059 shares of Omega Therapeutics Inc (OMGA) stock worth over $2 Million. Details can be seen in Flagship Pioneering Fund Vi General Partner Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Flagship Pioneering Fund Vi General Partner Llc has not made any transactions after 2021-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Flagship Pioneering Fund Vi General Partner Llc
Flagship Pioneering Fund Vi General Partner Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Fund Vi General Partner Llc owns 3 companies in total, including Seres Therapeutics Inc (MCRB) , Sana Biotechnology Inc (SANA) , and Omega Therapeutics Inc (OMGA) .
Insider Ownership Summary of Flagship Pioneering Fund Vi General Partner Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2019-06-18 | 10 percent owner |
| SANA | Sana Biotechnology Inc | 2021-02-03 | 10 percent owner |
| OMGA | Omega Therapeutics Inc | 2021-08-03 | 10 percent owner |
Flagship Pioneering Fund Vi General Partner Llc Latest Holdings Summary
Flagship Pioneering Fund Vi General Partner Llc currently owns a total of 1 stock. Flagship Pioneering Fund Vi General Partner Llc owns 2,197,059 shares of Omega Therapeutics Inc (OMGA) as of August 3, 2021, with a value of $2 Million.
Latest Holdings of Flagship Pioneering Fund Vi General Partner Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMGA | Omega Therapeutics Inc | 2021-08-03 | 2,197,059 | 1.13 | 2,482,677 |
Holding Weightings of Flagship Pioneering Fund Vi General Partner Llc
Flagship Pioneering Fund Vi General Partner Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Pioneering Fund Vi General Partner Llc has made a total of 1 transactions in Omega Therapeutics Inc (OMGA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Omega Therapeutics Inc is the acquisition of 1,176,469 shares on August 3, 2021, which cost Flagship Pioneering Fund Vi General Partner Llc around $20 Million.
Insider Trading History of Flagship Pioneering Fund Vi General Partner Llc
- 1
Flagship Pioneering Fund Vi General Partner Llc Trading Performance
GuruFocus tracks the stock performance after each of Flagship Pioneering Fund Vi General Partner Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Pioneering Fund Vi General Partner Llc is 60%. GuruFocus also compares Flagship Pioneering Fund Vi General Partner Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Pioneering Fund Vi General Partner Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Pioneering Fund Vi General Partner Llc's insider trading performs compared to the benchmark.
Performance of Flagship Pioneering Fund Vi General Partner Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.16 | | | | | |
| Relative Return to S&P 500(%) | 18.62 | | | | | |
Flagship Pioneering Fund Vi General Partner Llc Ownership Network
Ownership Network List of Flagship Pioneering Fund Vi General Partner Llc
Ownership Network Relation of Flagship Pioneering Fund Vi General Partner Llc
Flagship Pioneering Fund Vi General Partner Llc Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Flagship Pioneering Fund Vi General Partner Llc is the 10 percent owner of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Flagship Pioneering Fund Vi General Partner Llc made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,175 shares made by Teresa L. Young , a net sale of 33,802 shares made by Eric D. Shaff , and a net sale of 14,878 shares made by Moltke Lisa Von .
In summary, during the past 3 months, insiders sold 31,451 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,451 shares. During the past 18 months, 133,982 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,982 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Flagship Pioneering Fund Vi General Partner Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Pioneering Fund Vi General Partner Llc. You might contact Flagship Pioneering Fund Vi General Partner Llc via mailing address: 55 Cambridge Parkway, Suite 800e, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
